Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.

Dankner R, Boffetta P, Keinan-Boker L, Balicer RD, Berlin A, Olmer L, Murad H, Silverman B, Hoshen M, Freedman LS.

Diabetologia. 2016 Aug;59(8):1683-91. doi: 10.1007/s00125-016-3972-x. Epub 2016 May 17.

2.

Demography and disease characteristics of prostate cancer in India.

Hariharan K, Padmanabha V.

Indian J Urol. 2016 Apr-Jun;32(2):103-8. doi: 10.4103/0970-1591.174774. Review.

3.

Role of breast cancer inhibitors on diabetes mellitus- an in silico approach.

Rampogu SD.

J Diabetes Metab Disord. 2015 Mar 17;14:11. doi: 10.1186/s40200-015-0138-1. eCollection 2015.

4.

Tumor macroenvironment and metabolism.

Al-Zoughbi W, Huang J, Paramasivan GS, Till H, Pichler M, Guertl-Lackner B, Hoefler G.

Semin Oncol. 2014 Apr;41(2):281-95. doi: 10.1053/j.seminoncol.2014.02.005. Epub 2014 Mar 1. Review. Erratum in: Semin Oncol. 2014 Aug;41(4):e31. Al-Zhoughbi, Wael [corrected to Al-Zoughbi, Wael].

5.

Quality of Life and Sexual Health in the Aging of PCa Survivors.

Gacci M, Baldi E, Tamburrino L, Detti B, Livi L, De Nunzio C, Tubaro A, Gravas S, Carini M, Serni S.

Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17. Review. Erratum in: Int J Endocrinol. 2015;2015:675101.

6.

Diabetes and prostate cancer screening in black and white men.

Sanderson M, Fowke JH, Lipworth L, Han X, Ukoli F, Coker AL, Blot WJ, Hargreaves MK.

Cancer Causes Control. 2013 Oct;24(10):1893-9. doi: 10.1007/s10552-013-0257-2. Epub 2013 Jul 17.

7.

Pleiotropy between genetic markers of obesity and risk of prostate cancer.

Edwards TL, Giri A, Motley S, Duong W, Fowke JH.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1538-46. doi: 10.1158/1055-9965.EPI-13-0123. Epub 2013 Jun 27.

8.

Prostate cancer risk in pre-diabetic men: a matched cohort study.

Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich I, Williams GM, Doi SA.

Clin Med Res. 2013 Dec;11(4):201-9. doi: 10.3121/cmr.2013.1160. Epub 2013 May 8.

9.

Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Fowke JH, Motley S, Dai Q, Concepcion R, Barocas DA.

Cancer Lett. 2013 Jan 28;328(2):345-52. doi: 10.1016/j.canlet.2012.10.010. Epub 2012 Oct 16.

10.

Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India.

Ganesh B, Saoba SL, Sarade MN, Pinjari SV.

Indian J Urol. 2011 Jul;27(3):345-50. doi: 10.4103/0970-1591.85438.

11.

Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study.

Discacciati A, Orsini N, Andersson SO, Andrén O, Johansson JE, Wolk A.

Br J Cancer. 2011 Sep 27;105(7):1061-8. doi: 10.1038/bjc.2011.319. Epub 2011 Aug 16.

12.

Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.

Sun G, Kashyap SR.

J Nutr Metab. 2011;2011:708183. doi: 10.1155/2011/708183. Epub 2011 Jun 1.

13.
14.

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

He XX, Tu SM, Lee MH, Yeung SC.

Ann Oncol. 2011 Dec;22(12):2640-5. doi: 10.1093/annonc/mdr020. Epub 2011 Mar 17.

15.

The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study.

Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV.

BJU Int. 2011 Mar;107(6):929-35. doi: 10.1111/j.1464-410X.2010.09703.x. Epub 2010 Sep 29.

16.

Risk of cancer in a large cohort of U.S. veterans with diabetes.

Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA.

Int J Cancer. 2011 Feb 1;128(3):635-43. doi: 10.1002/ijc.25362.

17.

Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.

Pierce BL, Ahsan H.

Hum Hered. 2010;69(3):193-201. doi: 10.1159/000289594. Epub 2010 Mar 5.

18.

Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Neuhouser ML, Till C, Kristal A, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M.

Cancer Prev Res (Phila). 2010 Mar;3(3):279-89. doi: 10.1158/1940-6207.CAPR-09-0188. Epub 2010 Feb 23.

19.

Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.

Meyer TE, Boerwinkle E, Morrison AC, Volcik KA, Sanderson M, Coker AL, Pankow JS, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):558-65. doi: 10.1158/1055-9965.EPI-09-0902.

20.

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.

Jayachandran J, Aronson WJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):9-17. doi: 10.1158/1055-9965.EPI-09-0777.

Supplemental Content

Support Center